About this trial

This study has three primary objectives:

1. To adapt the Spanish version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP; Barlow et al., 2011, 2019a, 2019b) for delivery in a group format within the Spanish Public Mental Health System for adults diagnosed with emotional disorders. 2. To evaluate the effectiveness of the intervention. 3. To assess its clinical feasibility and acceptability in routine clinical practice.

Outcomes will include anxiety, depression, somatic symptoms, transdiagnostic variables, functional impairment, quality of life, and participant satisfaction. These outcomes will be assessed at baseline, post-treatment, and 3-month follow-up.

The intervention is expected to improve emotional symptoms, functional impairment, and quality of life. In addition, the study will explore whether this group-based transdiagnostic approach may help lower demand on public mental health services.

Eligibility criteria

Qualifiers

Aged 18 to 65 years.

Ability and willingness to provide written informed consent.

Sufficient proficiency in Spanish to participate in the intervention and complete study assessments.

Sufficient cognitive capacity to understand the intervention content.

Disqualifiers

Refusal to provide informed consent or withdrawal of consent during the study.

Current severe substance use disorder or behavioral addiction.

Current high suicide risk.

Current psychotic symptoms or psychotic disorder.

Trial design

Treatments tested in this trial

  • UP
  • TAU

Treatment groups

106 Participants
are divided into 2 treatment groups

Locations

1
Centro de Salud Espartero26007, LogroñoLa Rioja, Spain

Sponsors and collaborators

Patricia Fernández Couto

Lead sponsor

University of La Rioja

Sponsor institution

University of La Rioja

Collaborator